Visiting Scholars and Scientists

Kaelo Seatla

Fogarty Fellow

Global Health and Population

kseatla@hsph.harvard.edu

Links

Catalyst Profile

Education and Training

M.B.,B.S, 07/2008, Bachelor of Medicine, Bachelor of Surgery
University of the West Indies, St Augustine Campus, Trinidad

DTM&H, 11/2015, East African Diploma in Tropical Medicine and Hygiene
London School of Hygiene & Tropical Medicine, Tanzania & Uganda

PhD, 11/2021, Degree of Doctor of Philosophy in Medical Sciences
University of Botswana, Botswana

Bibliography

Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana.

Bareng OT, Seselamarumo S, Seatla KK, Choga WT, Bakae B, Maruapula D, Kelentse N, Moraka NO, Mokaleng B, Mokgethi PT, Ditlhako TR, Pretorius-Holme M, Mbulawa MB, Lebelonyane R, Bile EC, Gaolathe T, Shapiro R, Makhema JM, Lockman S, Essex M, Novitsky V, Mpoloka SW, Moyo S, Gaseitsiwe S.

J Glob Antimicrob Resist. 2022 Aug 13. 31:128-134. PMID: 35973671

Low-frequency HIV-1 drug resistance mutations in antiretroviral naïve individuals in Botswana.

Maruapula D, Seatla KK, Morerinyane O, Molebatsi K, Giandhari J, de Oliveira T, Musonda RM, Leteane M, Mpoloka SW, Rowley CF, Moyo S, Gaseitsiwe S.

Medicine (Baltimore). 2022 Jul 15. 101(28):e29577. PMID: 35838991

A fast-screening dispersive liquid-liquid microextraction-gas chromatography-mass spectrometry method applied to the determination of efavirenz in human plasma samples.

Masenga W, Paganotti GM, Seatla K, Gaseitsiwe S, Sichilongo K.

Anal Bioanal Chem. 2021 Oct. 413(25):6401-6412. PMID: 34557941

Limited HIV-1 Subtype C nef 3'PPT Variation in Combination Antiretroviral Therapy Naïve and Experienced People Living with HIV in Botswana.

Seatla KK, Maruapula D, Choga WT, Morerinyane O, Lockman S, Novitsky V, Kasvosve I, Moyo S, Gaseitsiwe S.

Pathogens. 2021 Aug 13. 10(8). PMID: 34451492

HIV-1 Subtype C Drug Resistance Mutations in Heavily Treated Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Botswana.

Seatla KK, Maruapula D, Choga WT, Ntsipe T, Mathiba N, Mogwele M, Kapanda M, Nkomo B, Ramaabya D, Makhema J, Mmalane M, Mine M, Kasvosve I, Lockman S, Moyo S, Gaseitsiwe S.

Viruses. 2021 03 31. 13(4). PMID: 33807382

Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana.

Maseng MJ, Tawe L, Thami PK, Seatla KK, Moyo S, Martinelli A, Kasvosve I, Novitsky V, Essex M, Russo G, Gaseitsiwe S, Paganotti GM.

Pharmgenomics Pers Med. 2021. 14:335-347. PMID: 33758532

Differences in human immunodeficiency virus-1C viral load and drug resistance mutation between plasma and cerebrospinal fluid in patients with human immunodeficiency virus-associated cryptococcal meningitis in Botswana.

Kelentse N, Moyo S, Mogwele M, Lechiile K, Moraka NO, Maruapula D, Seatla KK, Esele L, Molebatsi K, Leeme TB, Lawrence DS, Musonda R, Kasvosve I, Harrison TS, Jarvis JN, Gaseitsiwe S.

Medicine (Baltimore). 2020 Oct 09. 99(41):e22606. PMID: 33031315

Use of a mutation-specific genotyping method to assess for HIV-1 drug resistance in antiretroviral-naïve HIV-1 Subtype C-infected patients in Botswana.

Maruapula D, MacLeod IJ, Moyo S, Musonda R, Seatla K, Molebatsi K, Leteane M, Essex M, Gaseitsiwe S, Rowley CF.

AAS Open Res. 2020. 3:50. PMID: 34036243

In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana.

Choga WT, Anderson M, Zumbika E, Phinius BB, Mbangiwa T, Bhebhe LN, Baruti K, Kimathi PO, Seatla KK, Musonda RM, Bell TG, Moyo S, Blackard JT, Gaseitsiwe S.

Viruses. 2020 07 06. 12(7). PMID: 32640609

Comparison of an in-house 'home-brew' and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples.

Seatla KK, Choga WT, Mogwele M, Diphoko T, Maruapula D, Mupfumi L, Musonda RM, Rowley CF, Avalos A, Kasvosve I, Moyo S, Gaseitsiwe S.

PLoS One. 2019. 14(11):e0224292. PMID: 31751353

VIEW MORE PUBLICATIONS